Key result
Peripheral VA-ECMO 5-year survival varies widely by shock etiology, reaching ~57% in primary graft failure.
Why the study?
How do hospital and 5-year survival rates vary by shock etiology in adults supported with peripheral VA-ECMO?
Observational (n=1,253)
No
How do hospital and 5-year survival rates vary by shock etiology in adults supported with peripheral VA-ECMO?
Answers are grounded in this paper and cite their sources.
Survival outcomes for patients on VA-ECMO for cardiogenic shock are highly dependent on the underlying etiology, highlighting the need for etiology-specific prognostication and long-term follow-up.
BACKGROUND Outcomes of patients requiring venoarterial extracorporeal membrane oxygenation (VA-ECMO) vary greatly by etiology, but large studies that incorporate the spectrum of shock supported with ECMO are rare. OBJECTIVES The purpose of this study was to describe the etiology-related outcome of patients with shock supported with peripheral VA-ECMO. METHODS All consecutive adults with peripheral VA-ECMO between January 2015 and August 2018 at Pitié-Salpêtrière Hospital (Paris, France) were included in this retrospective observational study. The indication for VA-ECMO was cardiogenic shock. Rates of hospital death and neurological, renal, and pulmonary complications were evaluated according to etiology. RESULTS Among 1,253 patients, hospital and 5-year survival rates were, respectively, 73.3% and 57.3% for primary graft failure, 58.6% and 54.0% for drug overdose, 53.2% and 45.3% for dilated cardiomyopathy, 51.6% and 50.0% for arrhythmic storm, 46.8% and 38.3% for massive pulmonary embolism, 44.4% and 42.4% for sepsis-induced cardiogenic shock, 37.9% and 32.9% for fulminant myocarditis, 37.3% and 31.5% for acute myocardial infarction, 34.6% and 33.3% for postcardiotomy excluding primary graft failure, 25.7% and 22.8% for other/unknown etiology, and 11.1% and 0.0% for refractory vasoplegia shock. Renal failure requiring hemodialysis developed in 50.0%, neurological complications in 16.0%, and hydrostatic pulmonary edema in 9.0%. CONCLUSIONS Although the outcome differs depending on etiology, this difference is related more to the severity of the situation associated with the cause rather than the cause of the shock per se. Survival to 5 years varied by cause, which may reflect the natural course of the chronic disease and illustrates the need for long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Danial et al. (2023) conducted an observational in Cardiogenic shock requiring peripheral VA-ECMO (n=1,253). Shock etiology was evaluated on Hospital and 5-year survival rates. In adults requiring peripheral VA-ECMO for cardiogenic shock, 5-year survival varied widely by shock etiology, ranging from 57.3% for primary graft failure to 0.0% for refractory vasoplegia.
Synapse has enriched 10 related papers. Consider them for comparative context: